Archives triathlon-medical-ventures

by in
Entry Author Date Location
Migraine Drug Developer CoLucid Lands $37.1M for Phase 3 Trial 01/13/15 Raleigh Durham
Akebia Therapeutics Receives $41,000,000 Series C Round 06/05/13 Detroit Ann Arbor
Aerpio Therapeutics Garners $27,000,000 Series A Funding Round 09/01/12 Detroit Ann Arbor
Juventas Therapeutics Receives $22,200,000 Series B Financing 07/17/12 Detroit Ann Arbor
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines 05/18/12 Boston
Mitralign Lands $35,000,000 Series D Round 05/16/12 Boston
Celleration Secures $8,000,000 Series E Round 01/12/11 Detroit Ann Arbor
Tolera Therapeutics, Cleveland Clinic Spinoff Focused on Immune Disorders, Raises $4M 06/04/10 Detroit Ann Arbor
BioVex, Inc. Lands $40,000,000 Series F Financing Round 03/30/09 Boston
Hydrocision Secures New Financing Round 12/31/07 Boston
BioVex Completes $35 Million Financing 11/16/07 Boston
Page 1 of 1